MRI-TIME

  • Research type

    Research Study

  • Full title

    Magnetic Resonance Imaging and Thermal Imaging of Adiposity in Neonates of Women with Metabolic Diseases

  • IRAS ID

    287911

  • Contact name

    Kuberan Pushparajah

  • Contact email

    kuberan.pushparajah@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    2 years, 6 months, 0 days

  • Research summary

    Metabolic disease in pregnancy is known to affect a number of organ systems in both the mother and developing baby but there is limited knowledge about the extent of the impact upon fat (lipid) distribution and fat/heart function in the newborn baby, and how altered maternal blood lipid levels affect the baby. This study aims to investigate the effects of maternal metabolic disease on the fat content and distribution of the baby, and the appearance/function of different tissues including fat tissue, blood, muscle, liver and heart in the baby.

    To assess fat distribution, a process called thermal imaging (TI) will be used utilising a specialised camera at the bedside. In addition to this, the study will look in depth at the different tissues of the baby after they are born (fat tissue, muscle, liver, heart) using an MRI scan. A group of participants will undergo further detailed investigation of the heart including an ultrasound before they are born and ECG’s both before and after birth. Blood will be taken from the mother in pregnancy and the umbilical cord at birth (or newborn baby if no cord blood available) to look at markers of metabolic disease and sugar and fat levels which will be partnered with the information from the other investigations. The participants will also include a group of women with healthy, uncomplicated pregnancy as a control group.

    If there is evidence to show that there are any changes between children of women with metabolic disease and children of healthy pregnancies, it will help inform potential interventions and screening protocols in the future. This study will be conducted in St Thomas’ Hospital, London and the study is planned to be undertaken over a 30 month time period.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    21/PR/0162

  • Date of REC Opinion

    13 Apr 2021

  • REC opinion

    Further Information Favourable Opinion